356 related articles for article (PubMed ID: 23612225)
1. New insights into the role of sequestosome 1/p62 mutant proteins in the pathogenesis of Paget's disease of bone.
Rea SL; Walsh JP; Layfield R; Ratajczak T; Xu J
Endocr Rev; 2013 Aug; 34(4):501-24. PubMed ID: 23612225
[TBL] [Abstract][Full Text] [Related]
2. A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment.
Hiruma Y; Kurihara N; Subler MA; Zhou H; Boykin CS; Zhang H; Ishizuka S; Dempster DW; Roodman GD; Windle JJ
Hum Mol Genet; 2008 Dec; 17(23):3708-19. PubMed ID: 18765443
[TBL] [Abstract][Full Text] [Related]
3. A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Paget's disease of bone with a severe phenotype.
Rea SL; Walsh JP; Ward L; Yip K; Ward BK; Kent GN; Steer JH; Xu J; Ratajczak T
J Bone Miner Res; 2006 Jul; 21(7):1136-45. PubMed ID: 16813535
[TBL] [Abstract][Full Text] [Related]
4. p62 ubiquitin binding-associated domain mediated the receptor activator of nuclear factor-kappaB ligand-induced osteoclast formation: a new insight into the pathogenesis of Paget's disease of bone.
Yip KH; Feng H; Pavlos NJ; Zheng MH; Xu J
Am J Pathol; 2006 Aug; 169(2):503-14. PubMed ID: 16877352
[TBL] [Abstract][Full Text] [Related]
5. A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice.
Daroszewska A; van 't Hof RJ; Rojas JA; Layfield R; Landao-Basonga E; Rose L; Rose K; Ralston SH
Hum Mol Genet; 2011 Jul; 20(14):2734-44. PubMed ID: 21515589
[TBL] [Abstract][Full Text] [Related]
6. The p62 P392L mutation linked to Paget's disease induces activation of human osteoclasts.
Chamoux E; Couture J; Bisson M; Morissette J; Brown JP; Roux S
Mol Endocrinol; 2009 Oct; 23(10):1668-80. PubMed ID: 19589897
[TBL] [Abstract][Full Text] [Related]
7. Sequestosome 1 mutations in Paget's disease of bone in Australia: prevalence, genotype/phenotype correlation, and a novel non-UBA domain mutation (P364S) associated with increased NF-kappaB signaling without loss of ubiquitin binding.
Rea SL; Walsh JP; Ward L; Magno AL; Ward BK; Shaw B; Layfield R; Kent GN; Xu J; Ratajczak T
J Bone Miner Res; 2009 Jul; 24(7):1216-23. PubMed ID: 19257822
[TBL] [Abstract][Full Text] [Related]
8. A mutation in p62 protein (p. R321C), associated to Paget's disease of bone, causes a blockade of autophagy and an activation of NF-kB pathway.
Usategui-Martín R; Gestoso-Uzal N; Calero-Paniagua I; De Pereda JM; Del Pino-Montes J; González-Sarmiento R
Bone; 2020 Apr; 133():115265. PubMed ID: 32036052
[TBL] [Abstract][Full Text] [Related]
9. The S349T mutation of SQSTM1 links Keap1/Nrf2 signalling to Paget's disease of bone.
Wright T; Rea SL; Goode A; Bennett AJ; Ratajczak T; Long JE; Searle MS; Goldring CE; Park BK; Copple IM; Layfield R
Bone; 2013 Feb; 52(2):699-706. PubMed ID: 23117207
[TBL] [Abstract][Full Text] [Related]
10. Functional interaction between sequestosome-1/p62 and autophagy-linked FYVE-containing protein WDFY3 in human osteoclasts.
Hocking LJ; Mellis DJ; McCabe PS; Helfrich MH; Rogers MJ
Biochem Biophys Res Commun; 2010 Nov; 402(3):543-8. PubMed ID: 20971078
[TBL] [Abstract][Full Text] [Related]
11. Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bone.
Sundaram K; Shanmugarajan S; Rao DS; Reddy SV
Endocrinology; 2011 Nov; 152(11):4180-9. PubMed ID: 21878516
[TBL] [Abstract][Full Text] [Related]
12. Three novel mutations in SQSTM1 identified in familial Paget's disease of bone.
Johnson-Pais TL; Wisdom JH; Weldon KS; Cody JD; Hansen MF; Singer FR; Leach RJ
J Bone Miner Res; 2003 Oct; 18(10):1748-53. PubMed ID: 14584883
[TBL] [Abstract][Full Text] [Related]
13. Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease.
Hocking LJ; Lucas GJ; Daroszewska A; Mangion J; Olavesen M; Cundy T; Nicholson GC; Ward L; Bennett ST; Wuyts W; Van Hul W; Ralston SH
Hum Mol Genet; 2002 Oct; 11(22):2735-9. PubMed ID: 12374763
[TBL] [Abstract][Full Text] [Related]
14. Loss of ubiquitin-binding associated with Paget's disease of bone p62 (SQSTM1) mutations.
Cavey JR; Ralston SH; Hocking LJ; Sheppard PW; Ciani B; Searle MS; Layfield R
J Bone Miner Res; 2005 Apr; 20(4):619-24. PubMed ID: 15765181
[TBL] [Abstract][Full Text] [Related]
15. Mutant p62/SQSTM1 UBA domains linked to Paget's disease of bone differ in their abilities to function as stabilization signals.
Heinen C; Garner TP; Long J; Böttcher C; Ralston SH; Cavey JR; Searle MS; Layfield R; Dantuma NP
FEBS Lett; 2010 Apr; 584(8):1585-90. PubMed ID: 20230821
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of Paget's disease of bone.
Ralston SH
Bone; 2008 Nov; 43(5):819-25. PubMed ID: 18672105
[TBL] [Abstract][Full Text] [Related]
17. Paget's disease of bone in the French population: novel SQSTM1 mutations, functional analysis, and genotype-phenotype correlations.
Collet C; Michou L; Audran M; Chasseigneaux S; Hilliquin P; Bardin T; Lemaire I; Cornélis F; Launay JM; Orcel P; Laplanche JL
J Bone Miner Res; 2007 Feb; 22(2):310-7. PubMed ID: 17129171
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a non-UBA domain missense mutation of sequestosome 1 (SQSTM1) in Paget's disease of bone.
Najat D; Garner T; Hagen T; Shaw B; Sheppard PW; Falchetti A; Marini F; Brandi ML; Long JE; Cavey JR; Searle MS; Layfield R
J Bone Miner Res; 2009 Apr; 24(4):632-42. PubMed ID: 19049332
[TBL] [Abstract][Full Text] [Related]
19. Thirteen Chinese patients with sporadic Paget's disease of bone: clinical features, SQSTM1 mutation identification, and functional analysis.
Gu JM; Zhang ZL; Zhang H; Hu WW; Wang C; Yue H; Ke YH; He JW; Hu YQ; Li M; Liu YJ; Fu WZ
J Bone Miner Metab; 2012 Sep; 30(5):525-33. PubMed ID: 22491873
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profile in osteoclasts from patients with Paget's disease of bone.
Michou L; Chamoux E; Couture J; Morissette J; Brown JP; Roux S
Bone; 2010 Mar; 46(3):598-603. PubMed ID: 19925894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
